GMED

GLOBUS MEDICAL, INC.

GMED · CIK 1237831 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$2.9B
20182025
Net Income$0.5B
20182025
Operating CF$0.8B
20182025
Free Cash Flow$0.6B
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$2.9B$2.5B$1.6B$1.0B$1.0B$0.2B$0.2B$0.2B
Cost of Revenue$1.0B$1.0B$0.5B$0.3B$0.2B$0.2B$0.2B$0.2B
Gross Profit——$1.0B$0.8B$0.7B$0.2B$0.2B$0.1B
R&D Expense$0.1B$0.2B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
SG&A Expense$1.2B$1.0B$0.6B$0.4B$0.4B$0.4B$0.4B$0.3B
Operating Income$0.5B$0.2B$0.1B$0.2B$0.2B$0.1B$0.2B$0.2B
Net Income$0.5B$0.1B$0.1B$0.2B$0.1B$0.1B$0.0B$0.0B
EPS (Basic)$3.98$0.76$1.09$1.89$1.48$0.54$0.46$0.37
EPS (Diluted)$3.92$0.75$1.07$1.85$1.44$0.52$0.44$0.36

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$5.3B$5.3B$5.1B$2.1B$2.0B$1.7B$1.5B$1.3B
Current Assets$2.1B$2.2B$1.9B$1.0B$0.9B$0.8B$0.7B$0.6B
Cash & Equivalents$0.5B—————$0.2B$0.1B
Total Liabilities$0.7B$1.1B$1.1B$0.2B$0.2B$0.2B$0.1B$0.1B
Current Liabilities$0.5B$0.9B$0.4B$0.2B$0.1B$0.1B$0.1B$0.1B
Stockholders' Equity$4.6B$4.2B$4.0B$1.8B$1.7B$1.5B$1.4B$1.2B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.8B$0.5B$0.2B$0.2B$0.3B$0.2B$0.2B$0.2B
Investing Cash Flow$-0.4B$-0.2B$0.3B$-0.1B$-0.4B$-0.1B$-0.1B$-0.2B
Capital Expenditures$0.2B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
Financing Cash Flow$-0.7B$-0.0B$-0.2B$-0.1B$0.1B$-0.0B$0.0B$0.0B
← Companies